Holen Sie sich die Stockscreener-App
387.64
0.00%
0.00
Vorhandelsmarkt:
386.48
-1.16
-0.30%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Amgen Inc Aktie (AMGN) Neueste Nachrichten
Amgen (NASDAQ:AMGN) Sets New 12-Month HighTime to Buy? - MarketBeat
Amgen stock jumps as investors appear to look past Tavneos overhang and toward earnings - Quiver Quantitative
Amgen shares may move 4.6% on Aug. 4 earnings release By Investing.com - Investing.com South Africa
Earnings Preview: Amgen (AMGN) Q2 Earnings Expected to Decline - Yahoo Finance
Amgen (AMGN) Expected to Post Earnings on Tuesday - MarketBeat
Amgen stock hits all-time high at 391.3 USD - Investing.com
Amgen makes case to continue selling drug that FDA claims can be deadly - The Business Journals
Vanguard Health Care ETF Outperforms VanEck Biotech on Returns, Yield, and Fees - The Motley Fool
Barclays Adjusts Amgen Price Target to $360 From $350, Maintains Equalweight Rating - marketscreener.com
The Manufacturers Life Insurance Company Raises Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Bought by Quantinno Capital Management LP - MarketBeat
Empowered Funds LLC Sells 38,200 Shares of Amgen Inc. $AMGN - MarketBeat
Former AbbVie, Amgen exec Severino takes the reins at Sarepta - FirstWord Pharma
For Himself and His Daughters: One Father’s Journey with Thyroid Eye Disease (TED) - Amgen
Amgen stock trades steadily as investors weigh recent earnings and pipeline milestones - Ad-hoc-news.de
Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo! Finance Canada
Amgen price bolsters gainsForecast today27-07-2026 - Economies.com
Amgen Stock Erased a 17% Drawdown. A MariTide Switch Study Explains Why. - TIKR.com
Orbimed Advisors LLC Purchases Shares of 39,900 Amgen Inc. $AMGN - MarketBeat
Price-Driven Insight from (AMGN) for Rule-Based Strategy - Stock Traders Daily
Amgen stock extends focus on earnings and guidance - Ad-hoc-news.de
Amgen stock trades steadily as revenue growth and obesity pipeline shape investor focus - Ad-hoc-news.de
Amgen stock trades steady as oncology and cardiovascular pipeline supports valuation - Ad-hoc-news.de
Amgen (AMGN) Beat Revenue Forecasts, Is The Stock Overvalued? - simplywall.st
Amgen stock steadies after Q2 2026 growth - AD HOC NEWS
Lombard Odier Asset Management Switzerland SA Has $14.53 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Purchased by OMERS ADMINISTRATION Corp - MarketBeat
Amgen Inc. $AMGN Shares Sold by Healthcare of Ontario Pension Plan Trust Fund - MarketBeat
Entropy Technologies LP Buys Shares of 9,161 Amgen Inc. $AMGN - MarketBeat
Gabelli Funds LLC Reduces Stake in Amgen Inc. $AMGN - MarketBeat
Aristotle Atlantic Partners LLC Purchases Shares of 4,000 Amgen Inc. $AMGN - MarketBeat
Amgen stock trades steadily as oncology and cardiovascular pipeline supports long term growth - AD HOC NEWS
Amgen stock trims losses as Repatha data and oncology pipeline support long term growth - AD HOC NEWS
Why MrBeast, Stand Up To Cancer, and Amgen Joined Forces to Support Pediatric Cancer Research - Amgen
Amgen Inc (AMG) Q1 2026 Earnings ReportResults, Call & Slides - TipRanks
Amgen stock trades steadily as investors weigh Repatha growth and recent earnings - AD HOC NEWS
Amgen Inc (AMGN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Aristotle Capital Management LLC Lowers Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen stock edges higher as KRAS lung cancer data and revenue growth support outlook - AD HOC NEWS
Amgen stock trades steadily as recent earnings and obesity drug pipeline shape outlook - AD HOC NEWS
Amgen submits new data to challenge FDA's proposal to withdraw Tavneos - Reuters
Amgen Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Amgen shares new analysis with FDA in bid to keep Tavneos on the market - Endpoints News
Amgen stock trades steady as oncology and cardiovascular drugs support outlook - AD HOC NEWS
Amgen Inc. Revenue Breakdown – HAN:AMG - TradingView
Amgen hands in data package in hopes of FDA hearing for Tavneos defense - Fierce Pharma
Amgen submits new data to challenge FDA’s proposal to withdraw Tavneos - 1470 & 100.3 WMBD
Amgen stock trades steady as recent earnings and pipeline updates shape investor focus - AD HOC NEWS
Amgen Says Strongly Disagrees With FDA'S Proposal To Withdraw Tavneos From The U.S. Market - TradingView
Amgen Inc. $AMGN Shares Sold by Oak Associates Ltd. OH - MarketBeat
Public Employees Retirement System of Ohio Grows Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Bought by Sei Investments Co. - MarketBeat
Compound Planning Inc. Buys 7,818 Shares of Amgen Inc. $AMGN - MarketBeat
Dickmeyer Boyce Financial Management Inc. Acquires Shares of 2,888 Amgen Inc. $AMGN - MarketBeat
Amgen stock trades steady as biosimilar growth offsets mixed Q1 2026 trends - AD HOC NEWS
Amgen Inc. $AMGN Shares Acquired by Cetera Investment Advisers - MarketBeat
Bank of Nova Scotia Has $110.56 Million Stock Position in Amgen Inc. $AMGN - MarketBeat
Amgen Inc (AMGN) Institutional Confidence - TradingKey
Amgen stock trades steady as recent earnings and pipeline progress shape investor view - AD HOC NEWS
Therapeutics Stocks Q1 Teardown: Amgen (NASDAQ:AMGN) Vs The Rest - Yahoo Finance
What Amgen (AMGN)'s Blocked Colorado Enbrel Price Cap Means For Shareholders - simplywall.st
Amgen (AMGN) Rises As Market Takes a Dip: Key Facts - Yahoo Finance
Amgen Inc. stock outperforms competitors on strong trading day - MarketWatch
Amgen stock rises on earnings and pipeline progress - Ad-hoc-news.de
Amgen Inc (NASDAQ:AMGN) Shows Technical Strength and Breakout Setup - ChartMill
Amgen stock edges higher as oncology pipeline and restructuring savings shape outlook - Ad-hoc-news.de
Amgen Inc. $AMGN Shares Acquired by NewEdge Wealth LLC - MarketBeat
Amgen Inc. $AMGN Shares Bought by First Trust Advisors LP - MarketBeat
Amgen Inc (AMGN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Amgen stock holds near record levels as earnings and guidance frame the outlook - Ad-hoc-news.de
AMGN stock rises as 2025 revenue reaches $33.4 billion - Ad-hoc-news.de
Composition or Method? How Amgen and Teva Are Reshaping Drug Patent Strategy - JD Supra
0.06%
1.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):